Nicox S.A. (EPA:ALCOX)
France · Delayed Price · Currency is EUR 0.3455
-0.0085 (-2.40%)
Oct 17, 2025, 5:28 PM CET
Nicox Revenue
In the year 2024, Nicox had annual revenue of 7.86 million EUR with 13.84% growth. Nicox had revenue of 1.73 million in the half year ending June 30, 2023, with 31.09% growth.
Revenue
7.86M
Revenue Growth
+140.26%
P/S Ratio
3.56
Revenue / Employee
1.57M
Employees
5
Market Cap
27.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.86M | 955.64K | 13.84% |
| Dec 31, 2023 | 6.90M | 3.63M | 111.04% |
| Dec 31, 2022 | 3.27M | -3.96M | -54.78% |
| Dec 31, 2021 | 7.23M | -5.67M | -43.96% |
| Dec 31, 2020 | 12.91M | 6.05M | 88.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.74B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |